| 摘要 |
The invention relates to with novel thiazolidine derivatives of the formula <IMAGE> I wherein X is methylene, oxygen or sulfur; R1 is halogen; R2 is hydrogen, nitro, cyano, OR3 or NHR3; or R1 and R2 both simultaneously are hydrogen or nitro; R3 is hydrogen, alkyl, acyl, -CO-OR4 or -CO-NHR4; and R4 is alkyl, unsubstituted or substituted aryl or aralkyl, and their salts with physiologically compatible cations. The compounds of formula I are useful in the treatment of metabolic disorders.
|
